BioInformant

Your Global Leader in Stem Cell Market Research

Home » perinatal stem cells

Placental Stem Cells – The Rise of Placental Blood & Tissue Applications

By

In this interview with Dr. Ornella Parolini, Director of the E. Menni Research Center in Italy, we discussed her pioneering research on human placental stem cells. Her research is focused on the immunomodulatory and anti-inflammatory properties of amniotic and chorionic membrane cells. She is also President of the International Placenta Stem Cell Society (IPLASS), making her a globally recognized expert.

In addition to Dr. Robert Harari who holds a wide range of placental stem cell patents, Dr. Parolini is one of the world’s leading experts on placental stem cells and their therapeutic applications.

In this article:

[Read more…]

Definitive Guide To Perinatal Stem Cells

By

Perinatal stem cells are those derived right before or after birth. They include those derived from the umbilical cord blood and tissue, placental blood and tissue, and the amniotic tissue and amniotic fluid.

What are Perinatal Stem Cells?

However, when stem cells were first identified, only two types of stem cells were described, adult stem cells and embryonic stem cells. The reason a diverse range of stem cell types now exist is that human embryonic stem cells (hESCs) have become further characterized, the diversity of adult stem cell types has substantially expanded and induced pluripotent stem cells (iPSCs) have since been discovered.

Now, researchers debate the number of stem cells in existence, because the number depends on whether stem cells are characterized functionally (for example, neural stem cells, mesenchymal stem cells, and hematopoietic stem cells) or characterized by source tissue (for example, cord blood stem cells, dental pulp stem cells, and amniotic stem cells).

What is clear is that a wide range of stem cell types now exists, which has added substantial complexity to the stem cell landscape.
[Read more…]

Top 5 Stem Cell Interviews of 2015

By

As 2016 approaches, it is an important time to look back on 2015 and all that the year entailed for stem cell advances. During 2016, I was honored to have interviewed a number of key thought leaders in the stem cell space, including the CEO of the largest dental stem cell company in the world (Tony Veverka of BioEden), Chief Business Officer for a company creating the world’s largest blood cell repository for iPSC production (James Lovgren of ORIG3N), and VP of Research and Development for one of the most innovative companies operating within the stem cell sector (Dr. Grynspan of Stem Cell Medicine).

Throughout 2015, my team and I conducted dozens of other interviews as well, with stem cell executives, investors, and researchers. These interviews were published on our stem cell industry blog and also  informed market projections for BioInformant’s stem cell and cord blood market intelligence reports. [Read more…]

BioInformant's World-Class Clients